#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Keratosis follicular Insulinoma Pyoderma gangrenosum NTRK gene fusion overexpression Interstitial lung disease Hypoparathyroidism Extranodal marginal zone B-cell lymphoma (MALT type) Metastases to central nervous system Hyperinsulinism Immune-mediated myasthenia gravis Waldenstrom's macroglobulinaemia Myelin oligodendrocyte glycoprotein antibody-associated disease Spinal muscular atrophy Dermatitis Myeloid leukaemia More trials…

    Learn about Rare Diseases

    Brain stem glioma – Basic Information Brain stem glioma – Diagnostics Congenital hypotransferrinaemia – Diagnostics Ewing’s sarcoma – Basic Information Breast angiosarcoma metastatic – Treatment Breast angiosarcoma – Diagnostics Hairy cell leukaemia – Life with Disease Glomerulonephritis rapidly progressive Mitochondrial myopathy – Diagnostics Focal segmental glomerulosclerosis – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Alteplase Apitegromab Pabinafusp Alfa Glucocorticoids Ubiquinol Dazodalibep GT-002 ACETYLCARNITINE HYDROCHLORIDE Staphylococcus Aureus Urokinase [18F]Fluoro-Peg-Folate Levamlodipine Succinate Delafloxacin Atorvastatin Calcium FLUCLOXACILLIN SODIUM Flupentixol Decanoate Diltiazem Chloropyramine Hydrochloride PETHIDINE HYDROCHLORIDE Cdr132L Sodium More therapies…

    Learn about Your Condition

    Pulmonary hypertension Periarthritis Perthes disease Precocious puberty Anaemia of pregnancy Alveolar proteinosis Myopia Von Hippel-Lindau disease Colon cancer stage III Neoplasm malignant Toxicity to various agents Alport's syndrome Fallopian tube cancer stage IV Systemic infection Respiratory tract infection More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Urticaria chronic

  • Evaluation of remibrutinib (LOU064) effectiveness and safety in adult patients with chronic urticaria: A 12-week placebo-controlled study

    Recruiting

    2 1 1
    Investigated Diseases:
    • Urticaria chronic
    Investigated Drugs:
    • Remibrutinib
    France Germany Poland Spain

  • Study of BLU-808 tablets compared to placebo in adults with chronic inducible urticaria and chronic spontaneous urticaria

    Not recruiting

    2 1
    Denmark Germany Italy Spain

  • Study on Long-Term Safety of Briquilimab for Patients with Chronic Urticaria

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Urticaria chronic
    Investigated Drugs:
    • Briquilimab
    Germany

  • Study on Remibrutinib for Adults with Chronic Inducible Urticaria Uncontrolled by H1-Antihistamines

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Urticaria cholinergic
    • Cold urticaria
    • Urticaria chronic
    Investigated Drugs:
    • Remibrutinib
    France Germany Hungary Italy The Netherlands Poland +4

  • Study on Briquilimab for Adults with Chronic Inducible Urticaria Unresponsive to H1-Antihistamines

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Urticaria chronic
    Investigated Drugs:
    • Adrenaline Tartrate Ph. Eur.
    • Briquilimab
    Germany

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!